You are here: Home > Clinical Trials & Research > Lymphoma
Lymphoma
| 50303 | Lead group: CALGB |
| Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-cell Lymphomas | |
| IM-T-hA20-08 | |
| Phase I/II Study of Subcutaneously Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | |
We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.
For more information about the clinical trials listed please go to http://www.clinicaltrials.gov/.
Page last updated: 11/12/2008 | Recommend this page | Printer friendly version
